XML 73 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Details) - Schedule of activity under the stock option plans - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Stockholders' Equity (Details) - Schedule of activity under the stock option plans [Line Items]    
Weighted Average Exercise Price, Outstanding, Beginning (in Dollars per share) $ 6.38 $ 6.48
Aggregate Intrinsic Value, Outstanding, Beginning (in Dollars) [1] $ (180,038) $ (516,475)
Weighted Average Exercise Price, Outstanding, Ending (in Dollars per share) $ 6.90 $ 6.38
Aggregate Intrinsic Value, Outstanding, Ending (in Dollars) [1] $ 1,150,755 $ (180,038)
Weighted Average Exercise Price, Vested (in Dollars per share) $ 6.72  
Aggregate Intrinsic Value, Vested (in Dollars) [1] $ 746,280  
Weighted average exercise price, Vested and expected to vest (in Dollars per share) $ 6.90  
Aggregate Intrinsic Value, Vested and expected to vest (in Dollars) [1] $ 1,150,755  
Grants 72,000  
Weighted Average Exercise Price, Grants (in Dollars per share) $ 9.79 $ 5.03
Weighted Average Exercise Price, Terminations/forfeitures (in Dollars per share) 6.49 5.45
Weighted Average Exercise Price, Exercises (in Dollars per share) $ 7.08 $ 3.15
2010 Plan [Member]    
Stockholders' Equity (Details) - Schedule of activity under the stock option plans [Line Items]    
Outstanding, Beginning balance 237,500 255,000
Outstanding, Ending balance 223,500 237,500
Vested 183,500  
Vested and expected to vest 223,500  
Reserved for future grants  
Grants 7,000
Terminations/forfeitures (7,000) (12,000)
Exercises (7,000) (12,500)
2017 Plan [Member]    
Stockholders' Equity (Details) - Schedule of activity under the stock option plans [Line Items]    
Outstanding, Beginning balance 176,500 133,500
Outstanding, Ending balance 218,500 176,500
Vested 84,500  
Vested and expected to vest 218,500  
Reserved for future grants 63,500  
Grants 72,000 93,000
Terminations/forfeitures (12,000) (50,000)
Exercises (18,000)
[1] Intrinsic value is the difference between the fair market value of the underlying common stock as of the date indicated and as of the date of the option grant (which is equal to the option exercise price).